Delivery Order SPE2DR25D2006-SPE2DR26F57EU
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,829.09 to AmerisourceBergen Drug Corp for the supply of SPRAVATO 84 mg dose pack UDS (unit dose packages). This firm fixed price delivery order, awarded on July 28, 2025, with an ultimate completion date of July 29, 2025, represents a non-competitive set-aside contract and will be performed at the contractor's facility in Conshohocken, Pennsylvania. SPRAVATO (esketamine) is a prescription nasal spray used in treating...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,336.81 to AmerisourceBergen Drug Corp for the supply of Spravato 84 mg dose pack UDS (unit dose system). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 8, 2025, and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a $5,616.08 firm fixed price delivery order to AmerisourceBergen Drug Corp for SPRAVATO 84 mg dose pack UDS (unit dose packs) with a completion date of September 26, 2025. This non-set-aside competitive award was issued on September 25, 2025, with performance to occur at the contractor's facility in Conshohocken, Pennsylvania. SPRAVATO (esketamine) is a specialized nasal spray medication indicated for treatment-resistant depression, representing a critical...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of SPRAVATO 84 MG DOSE PACK medical supplies. The order, valued at $22,963.32, has a completion date of January 26, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which was not set aside for any specific business type. Amerisourcebergen Drug Corp also...
- The Defense Logistics Agency awarded a delivery order valued at $6,238.82 to AmerisourceBergen Drug Corp for the supply of Spravato 84 mg dose pack unit dose systems on December 26, 2025, with an ultimate completion date of December 29, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded a delivery order valued at $8.55K to AmerisourceBergen Drug Corp for the supply of Spravato 84 mg dose pack UDS (unit dose system) pharmaceutical product. This is a firm fixed price delivery order with no set-aside designation, competitively awarded on December 29, 2025, with an ultimate completion date of December 30, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $26,633.16 firm fixed price delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Spravato 84 mg dose pack UDS (unit dose systems). The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The contract was competitively awarded without set-aside provisions. Performance...
- The Defense Logistics Agency awarded a delivery order valued at $1,625.24 to AmerisourceBergen Drug Corp for Spravato 56 mg dose pack unit dose system (UDS) pharmaceutical products. This competitive, non-set-aside contract was awarded on December 22, 2025, with an ultimate completion date of December 23, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Spravato is a specialized nasal spray medication used in the treatment of major...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,860.83 firm-fixed-price delivery order is for SPRAVATO 84 MG DOSE PACK UDS, a medication, with an ultimate completion date of July 11, 2025. This contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of SPRAVATO 84 MG DOSE PACK UDS pharmaceutical products. The order has a completion date of March 1, 2024 and a potential value of $15,308.88. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. This delivery order is issued under a...
- SPE2DR25D2006Indefinite Delivery Contract
- SPE2DR25D2006-SPE2DR26F57EUDelivery Order
The Defense Logistics Agency awarded a $9,601.74 firm fixed-price delivery order to Amerisourcebergen Drug Corp for SPRAVATO 84 mg dose pack units of use on January 8, 2026, with completion targeted for January 9, 2026. This non-competitive delivery order, issued under a larger indefinite delivery contract vehicle, represents a pharmaceutical supply fulfillment to support federal military and healthcare system requirements. Amerisourcebergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a subsidiary of Cencora, Inc. (formerly operating under the Amerisourcebergen name), a major pharmaceutical distributor providing critical medical products to government agencies. This delivery order falls under Amerisourcebergen Drug Corp's substantial indefinite delivery contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle supplying an extensive range of brand-name and generic medications, specialty drugs, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare programs, the Defense Health Agency, U.S. Coast Guard, and other federal medical institutions. SPRAVATO (esketamine) is a prescription nasal spray medication used for treatment-resistant depression, representing the specialized pharmaceutical commodities that fall within the contract's scope of medical supply delivery to federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.6k | 1/7/26 |